The Hydropothecary Corporation

Latest The Hydropothecary Corporation News and Updates

  • HEXO worker in a marijuana plant
    Cannabis

    Should Investors Buy HEXO (HEXO) Stock on the Dip or Wait?

    HEXO stock has returned 88 percent YTD. Recently, the stock has lost some of its value. Will HEXO stock fall more or go up?
    By Ambrish Shah
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis’s Revenue: Here’s What Analysts Expect

    Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Aurora Cannabis’s Price Target Cut by 30%

    Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

    By Margaret Patrick
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///Can_
    Cannabis

    What Do Analysts Recommend for Canopy Growth?

    On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.

    By Rajiv Nanjapla
  • uploads///ebitda
    Real Estate

    Comparing the Valuation Multiples of Cannabis Stocks

    In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

    By Adam Jones
  • uploads///Cronos group
    Cannabis

    Cronos Group Joins Altria to Bet on Cannabidiol Market

    Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

    By Sushree Mohanty
  • uploads///arnel hasanovic oWSXdeASg unsplash
    Cannabis

    Why Canopy Growth Isn’t Happy with Apple

    Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

    By Sushree Mohanty
  • uploads///south dakota cannabis
    Cannabis

    South Dakota Plans for Marijuana Legalization amid COVID-19

    Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.

    By Sushree Mohanty
  • uploads///hand holding medicine
    Cannabis

    Why Medical Cannabis Lacks Scientific History

    Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Cannabis Stocks Continue to Struggle on the Last Day of April

    The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

    By Adam Jones
  • uploads///Medical cannabis
    Cannabis

    Medical Cannabis in Brazil Is Coming

    According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Will Trump Have an Edge over Biden?

    With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Aphria: Why Jefferies Recommends a ‘Buy’

    Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.

    By Sushree Mohanty
  • uploads///Canopy
    Cannabis

    Canopy Gets Estimates Revised by Analysts for 2020

    Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis 3.0: Is It on the Horizon?

    On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Valuation for Cannabis Stocks in October

    The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

    By Margaret Patrick
  • uploads///canopy growth pi financial
    Cannabis

    Canopy Growth: Why PI Financial Suggests a ‘Sell’

    Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Why Is Washington Changing Its Laws?

    In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

    By Sushree Mohanty
  • uploads///texas
    Cannabis

    Marijuana in Texas: Five Things You Should Know

    Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Beverages: Why Canadians Can’t Wait

    Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.

    By Sushree Mohanty
  • uploads///CGC_
    Cannabis

    Why Does Jim Cramer Prefer CGC versus CRON?

    Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.

    By Rajiv Nanjapla
  • uploads///cannabis edibles
    Cannabis

    No Cannabis Edibles in Three Provinces for Christmas

    After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.

    By Sushree Mohanty
  • uploads///cannabsis
    Cannabis

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

    By Sushree Mohanty
  • uploads///Household Consumption Expenditure on Cannabis
    Company & Industry Overviews

    Why Cannabis Stocks Are on the Rise

    The reason cannabis stocks are rising could be because October 17 is approaching.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Was CGC a Big Mistake for Constellation Brands?

    Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.

    By Margaret Patrick
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Wants to Grow Cannabis Outdoors

    Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///Canopy Growth
    Cannabis

    What’s Canopy Growth Strategy for Growth?

    Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.

    By Sushree Mohanty
  • uploads///IIPR
    Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///arizona marijuana ballott
    Cannabis

    Arizona’s Marijuana Campaign Qualifies for November Ballot

    Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: What’s Happening in Utah?

    Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Has Irwin Simon Really Turned Aphria Around?

    Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.

    By Sushree Mohanty
  • uploads///Republicans
    Cannabis

    Do Republicans Want to Join the Cannabis Action?

    Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.

    By Sushree Mohanty
  • uploads///marijuanaI
    Cannabis

    New Year Will Bring Legal Marijuana to Illinois Residents

    Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Why Did Mexico Delay Legalization?

    Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Raymond James Foresees a Cannabis Rebound in 2020

    Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]

    By Sushree Mohanty
  • uploads///seedling _
    Company & Industry Overviews

    The Market Is Sinking and Taking the Cannabis Sector Along

    This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.

    By Adam Jones
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • Cannabis

    New Gallup Poll on Marijuana Legalization Support

    A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]

    By Anjana Viswanathan
  • uploads///Aphria
    Cannabis

    Analysts Neutral on Aphria’s 2020 Outlook in December

    Aphria has successfully impressed investors compared to other cannabis companies this year, even though the same factors have affected the entire industry.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Cannabis Stocks: What Happens in a Recession?

    As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

    By Margaret Patrick
  • uploads///south dakota marijuana
    Cannabis

    Marijuana Legalization in South Dakota Lies with Voters Now

    Marijuana legalization in South Dakota could see daylight in 2020. The state passed measures to legalize both recreational and medical marijuana.

    By Sushree Mohanty
  • Cannabis

    Know the Pros and Cons of Cannabis Edibles

    Deloitte says that the Canadian edibles market could reach 2.7 billion Canadian dollars per year. Cannabis 2.0 could help cannabis stocks recover.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis: Will Top Companies’ Earnings Be a Relief?

    The cannabis earnings season has started again. Earnings season is an exciting time for investors who have been eyeing the sector.

    By Sushree Mohanty
  • uploads///canopy growth buy
    Cannabis

    Must-Know: Is Canopy Growth Still a Buy?

    For fiscal 2020, analysts expect Canopy Growth to report revenues of 404.5 million Canadian dollars—a rise of 78.7% from fiscal 2019.

    By Rajiv Nanjapla
  • uploads///cannabis sector pitfalls
    Cannabis

    Coronavirus Revealed Cannabis Supply Chain’s Pitfalls

    The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain. 

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Regulators Beware: Cannabis Linked to Job Loss

    Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.

    By Sushree Mohanty
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///p
    Cannabis

    Curaleaf Stock: Latest Updates for Investors

    Lately, Curaleaf (CURLF) stock received some attention from cannabis investors. The company announced the acquisition of GR Companies on July 17. The acquisition would make Curaleaf one of the biggest cannabis companies. To learn more, read Curaleaf Will Soon Be the World’s Largest Cannabis Company. After the announcement, Curaleaf stock closed almost 17% higher at […]

    By Market Realist
  • uploads///Organigram
    Cannabis

    Organigram Has Analysts Confident ahead of Q1 Earnings

    Organigram is set to report its fiscal 2020 first-quarter earnings on January 14. The company’s fiscal 2019 fourth-quarter results were stable.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Are Cannabis Edibles Coming to Maryland Soon?

    Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.

    By Sushree Mohanty
  • uploads///tim gouw bwkiap y unsplash
    Cannabis

    Get Real: Breaking Down and Bouncing Back

    In this morning’s edition of Get Real, we saw that WeWork’s layoffs are taking a toll. Meanwhile, the cannabis industry could be bouncing back.

    By Grace Nightingale
  • uploads///marijuana fed reserve bank
    Cannabis

    Marijuana Legalization Catches Federal Reserve Bank’s Attention

    The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.

    By Sushree Mohanty
  • uploads///Hexo
    Cannabis

    Will Hexo Continue to Struggle in 2020?

    For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.

    By Sushree Mohanty
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Comparing Cannabis Stocks’ Valuation Multiples in November

    Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Cannabis Corruption in the US: Trouble before Elections?

    Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Marijuana Sales Soar amid Coronavirus Pandemic

    Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.

    By Sushree Mohanty
  • uploads///constellation brands belief canopy growth
    Cannabis

    Constellation Still Believes in Canopy Growth, Should You?

    Canopy Growth (NYSE:CGC) has always been a hot cannabis stock. The company’s deal with Constellation Brands (NYSE:STZ) makes the stock even more attractive.

    By Sushree Mohanty
  • uploads///hexo israel marijuana
    Cannabis

    HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%

    Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.

    By Rajiv Nanjapla
  • uploads///dea
    Cannabis

    Analyzing the Top 3 CBD Companies to Buy in July

    Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.

    By Rajiv Nanjapla
  • uploads///nebraska marijuana
    Cannabis

    Marijuana Legalization Hopes Rise in Nebraska for 2020

    Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Still Has a Chance in Idaho

    Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.

    By Sushree Mohanty
  • uploads///aphria and organigram comparing
    Cannabis

    Is Aphria or OrganiGram a Better Buy for Investors?

    Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.

    By Rajiv Nanjapla
  • uploads///OGI_
    Cannabis

    What to Expect from OrganiGram’s Q3 Earnings

    OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.

    By Rajiv Nanjapla
  • uploads///curaleaf
    Cannabis

    Is Curaleaf a Good Cannabis Pick in 2020?

    Curaleaf (OTCMKTS:CURLF) is one of the vertically integrated US cannabis companies. The company has been a top player in the US cannabis space.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Cronos and Altria’s Deal: Does It Make Sense Now?

    Cronos Group, one of the more resilient cannabis stocks, hasn’t escaped the gloom in the cannabis sector. It’s down 37.44% year-to-date on the Nasdaq.

    By Margaret Patrick
  • uploads///aurora cannabis revision march
    Cannabis

    Analysts Revise Estimates for Aurora Cannabis in March

    Analysts are skeptical due to Aurora Cannabis’s recent string of bad news. The stock could get delisted. However, analysts still have hope for the company.

    By Sushree Mohanty
  • uploads///canopy growth cannabis
    Cannabis

    Canopy Growth Lays Off More Employees, Latest Strategic Review Round

    Canopy Growth laid off an unspecified number of employees on Thursday. So far, the company has laid off 800 employees this year.

    By Rajiv Nanjapla
  • uploads///marijuana stocks july
    Cannabis

    What to Expect from Marijuana Stocks in July

    OrganiGram will likely report its earnings for the third quarter of fiscal 2020 on July 13. We’ll have to see if marijuana stocks recover in July.

    By Sushree Mohanty
  • uploads///Acb_
    Cannabis

    Why Did Raymond James Downgrade OrganiGram?

    On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

    By Rajiv Nanjapla
  • uploads///aurora cannabis analysts bullish
    Cannabis

    Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish

    Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.

    By Sushree Mohanty
  • uploads///aurora cannabis aphria cantor fitzgerald
    Cannabis

    Aurora Cannabis Announces Job Cuts and Facility Closures

    On Tuesday, Aurora Cannabis (NYSE:ACB) provided an update on its business transformation plan, which it announced earlier this year.

    By Rajiv Nanjapla
  • uploads///Canopy_Growth_
    Cannabis

    Canopy Growth Announces Initiatives to Regain Market Share

    In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Why Canadian Cannabis Sales Dipped Slightly in April

    In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’

    Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.

    By Rajiv Nanjapla
  • uploads///rick proctor PGcVidO unsplash
    Cannabis

    HEXO and Aurora Cannabis Stock, Investors Should Think Twice

    HEXO and Aurora Cannabis posted an impressive set of numbers in the third quarter. During the third quarter, HEXO’s net revenues surged about 70% YoY.

    By Amit Singh
  • uploads///AdobeStock_
    Cannabis

    Why HEXO Stock Tanked More than 11% on Wednesday

    On Wednesday, HEXO announced a new at-the-market equity program, which would allow it to issue common shares worth up to 34.5 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///hexo wall street expectations
    Cannabis

    Wall Street’s Expectations after Hexo’s Q3 Earnings

    Hexo (TSE:HEXO) reported better-than-expected results for the third quarter of fiscal 2020 last week. The company repeatedly disappointed investors in 2019.

    By Sushree Mohanty
  • uploads///hexo mixed results
    Cannabis

    Hexo Beat the Revenue Estimates, Posted Q3 Loss

    Hexo beat the revenue estimates of 19.9 million Canadian dollars. However, the company reported a quarterly EBITDA loss of 4.3 million Canadian dollars.

    By Sushree Mohanty
  • uploads///OrganiGram_
    Cannabis

    OrganiGram Stock Rose Due to New International Agreement

    On Wednesday, OrganiGram Holdings (NASDAQ:OGI) announced that its subsidiary OrganiGram signed a supply agreement with Canndoc.

    By Rajiv Nanjapla
  • uploads///arkansas marijuana
    Cannabis

    Marijuana Legalization Campaign in Arkansas Gets a Boost

    US states have been looking at strategies to gather signatures and qualify for the 2020 ballot. The pandemic made gathering signatures a challenge.

    By Sushree Mohanty
  • uploads///canopy growth cannabis
    Cannabis

    Is Canopy Growth a ‘Buy’ after Its Recent Pullback?

    Since Canopy Growth (NYSE:CGC)(TSE:WEED) reported its results for the fourth quarter of fiscal 2020, it has lost 22.4% of its stock value as of Tuesday.

    By Rajiv Nanjapla
  • uploads///hexo upcoming results q
    Cannabis

    Will Hexo’s Q3 Earnings Bring Positive News?

    Hexo (TSE:HEXO) will likely report its results for the third quarter of fiscal 2020 on Thursday before the market opens. The stock has been struggling.

    By Sushree Mohanty
  • uploads///hexo
    Earnings Report

    Will Hexo Stock Keep Rising after Its Q3 Earnings?

    Hexo (TSE:HEXO) stock has been rising high before its third-quarter earnings results. The company will likely report its results before the market bell on Thursday.

    By Sophia Nicholson
  • uploads///bermuda cannabis market
    Cannabis

    Bermuda Seeks Public Feedback on Legal Cannabis Market

    Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions.

    By Sushree Mohanty
  • uploads///Jim Cramer
    Cannabis

    Why Is HEXO Rising before Its Q3 Earnings?

    HEXO (TSE:HEXO) will likely report its third-quarter earnings before the market opens on June 11. So far, HEXO has lost 58.9% of its stock value this year.

    By Rajiv Nanjapla
  • uploads///hexo pass
    Cannabis

    Why Lorne Steinberg Thinks Hexo Is a Pass

    Lorne Steinberg thinks that even after Hexo’s deal with Molson Coors, it still doesn’t look attractive. He would rather find value somewhere else.

    By Sushree Mohanty
  • uploads///aurora cannabis q results announce
    Cannabis

    Aurora Cannabis Continues to Shine: Should You Book Profits?

    As of June 5, Aurora Cannabis was trading at 18.79 Canadian dollars—a rise of 104.2% since it reported its third-quarter earnings.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    HEXO Launches New Tsunami Format, Targets Medical Customers

    On Wednesday, HEXO launched its high-THC strain Tsunami in a new 30-gram pack exclusively for medical usage. The launch impressed investors.

    By Rajiv Nanjapla
  • uploads///Cresco Labs
    Cannabis

    HEXO Received License Amendment, Stock Rose Monday

    On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.

    By Rajiv Nanjapla
  • uploads///hexo clock
    Cannabis

    Hexo Receives NYSE Warning for Listing, Clock Is Ticking

    On April 7, the NYSE sent a listing notification to Hexo. The warning said that the stock fell below the NYSE’s $1.00 share price continued listing standard.

    By Sushree Mohanty
  • uploads///APH_
    Cannabis

    Why Has Aphria Risen in Today’s Pre-Trading Hours?

    Today, Aphria (NYSE:APHA) announced that ASG Pharma has received EU GMP certification to produce cannabis for medical and research purposes.

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Constellation Brands Hikes Its Stake in Canopy Growth

    Constellation Brands (NYSE:STZ) expressed its confidence in Canopy Growth (NYSE:CGC)(TSE:WEED) by increasing its stake in the company.

    By Rajiv Nanjapla
  • uploads///matteo paganelli MqISkmiLGc unsplash
    Cannabis

    Is Aphria a Viable Investment in the Cannabis Space?

    Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive.

    By Amit Singh
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.